RxDoctor Payments Data

Wood Gibbs, MD

Gastroenterology · New Bern, NCNPI 1740405323

Payments from drug & device makers

$1,565in general payments, 2019–2025

Across 78 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$756
  • Pentax Of America, Inc.$183
  • Cook Medical LLC$154
  • Enterra Medical, Inc.$136
  • Boston Scientific$82
  • Ambu Inc.$46
  • plus $208 from 12 others

What the payments were for

  • Food & beverage$1,55199%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,565 in reported general payments places this provider in the 40th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina

Medicare billing

Part B allowed, 2024
$178,601
Medicare patients
511
Services billed
2,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab14$414,423
EntyvioVedolizumab12$100,047
SimponiGolimumab13$89,138
XeljanzTofacitinib Citrate12$80,599
XifaxanRifaximin17$60,289
LinzessLinaclotide53$37,049
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl194$3,254
Budesonide DrBudesonide20$2,887
Ursodiol27$2,602
Omeprazole252$2,093
Mesalamine15$1,996
Pantoprazole Sodium193$1,553
Famotidine154$1,307
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl75$1,222
Entecavir16$1,113

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara, Simponi$18$503,56127 claims
Takeda Pharmaceuticals U.S.A., Inc.Entyvio$16$100,04712 claims
PfizerXeljanz$26$80,59912 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$17$60,28917 claims
AbbVieLinzess$756$37,04953 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 610 gastroenterology providers in North Carolina.

Other gastroenterology in New Bern

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →